Stockscreener 앱 받기
10.41
7.47%
-0.84
시간 외 거래:
10.50
0.09
+0.86%
Kura Oncology Inc 주식(KURA)의 최신 뉴스
KURA: Strong launch and clinical data drive optimism for growth in AML and solid tumor markets - TradingView
KURA: Strong launch and robust clinical data position therapies for major growth in AML and solid tumors - TradingView
Kura Oncology reports strong tumor shrinkage with darlifarnib + adagrasib in KRAS G12C-mutated cancers. - Pluang
KURA: Promising Results from FIT-001 Trial of Darlifarnib - GuruFocus
Kura Oncology reports tumor shrinkage in cancer drug trial - Investing.com
Kura Oncology reports tumor shrinkage in cancer drug trial By Investing.com - Investing.com Canada
Kura Oncology Reports Promising Phase 1 Results for Darlifarnib in Combination with Adagrasib in KRAS G12C-Mutated Tumors - Quiver Quantitative
Experimental drug combo shrinks tumors in 77% of advanced cancer patients - Stock Titan
Kura Oncology’s SWOT analysis: biotech stock faces launch test By Investing.com - Investing.com India
Kura Oncology’s SWOT analysis: biotech stock faces launch test - Investing.com UK
Insider Sell Alert: Brian Powl Sells 10,000 Shares of Kura Oncol - GuruFocus
Kura Oncology (KURA) CCO sells 10,000 shares in planned trade - Stock Titan
KURA Stock Price, Quote & Chart | KURA ONCOLOGY INC (NASDAQ:KURA) - ChartMill
KURA (NASDAQ: KURA) files Form 144 reporting proposed sale of 10,000 RSUs - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Kura Oncology COO Kathleen Ford sells $20,482 in stock By Investing.com - Investing.com South Africa
Insider Sell: Brian Powl Sells Shares of Kura Oncology Inc (KURA) - GuruFocus
Kura Oncology COO Kathleen Ford sells $20,482 in stock - Investing.com
Kathleen Ford Sells 2,257 Shares of Kura Oncology Inc (KURA) - GuruFocus
Kura Oncology (KURA) CCO sells 339 shares while retaining 183,614 - Stock Titan
Kura Oncology (KURA) COO sells 2,257 shares under pre-set trading plan - Stock Titan
[Form 4] Kura Oncology, Inc. Insider Trading Activity - Stock Titan
KURA News | KURA ONCOLOGY INC (NASDAQ:KURA) - ChartMill
[144] Kura Oncology, Inc. SEC Filing - Stock Titan
Kura Oncology to Present at TD Cowen 7th Annual Oncology Innovation Summit - The Manila Times
Kura Oncology Q1 earnings call highlights - MSN
Kura Oncology’s SWOT analysis: stock faces launch challenges despite FDA approval - Investing.com UK
Kura Oncology’s SWOT analysis: biotech stock faces launch challenges - Investing.com
Kura Oncology’s SWOT analysis: biotech stock faces launch challenges By Investing.com - Investing.com Nigeria
Earnings call transcript: Kura Oncology Q1 2026 revenue miss overshadows stable EPS - Investing.com UK
Some Analysts Just Cut Their Kura Oncology, Inc. (NASDAQ:KURA) Estimates - Yahoo Finance
Kura Oncology stock (US50126D1028): FDA breakthrough nod and pipeline update draw investor focus - AD HOC NEWS
LifeSci Capital Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $28 - Moomoo
UBS Group AG Acquires 574,455 Shares of Kura Oncology, Inc. $KURA - MarketBeat
Kura Oncology (NASDAQ:KURA) Rating Increased to Hold at Wall Street Zen - MarketBeat
Kura Oncology Inc (KURA) Stock Price, Quote, News & History - Benzinga
Armistice Capital (KURA) holds 3.74M shares, 4.23% stake via Master Fund - Stock Titan
0.98%
0.12%
자본화:
|
볼륨(24시간):